
Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "AREA[SponsorSearch](Ocular Therapeutix, Inc.)"
Count: 53
Selected: 0
NCT ID | Title |
---|
NCT02988882 | OTX-15-002: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Chronic Allergic Conjunctivitis | ||
NCT02468700 | OTX-14-006: A Phase 2 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Dry Eye | ||
NCT02445326 | OTX-14-007: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Chronic Allergic Conjunctivitis | ||
NCT02062905 | OTX-14-001: A Phase 2 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Chronic Allergic Conjunctivitis | ||
NCT05814757 | OTX-DED for the Short-term Treatment of the Symptoms of Dry Eye Disease (DED) | ||
NCT05695417 | Study to Evaluate the Safety, Tolerability, and Efficacy of OTX-TKI in Subjects With Moderately Severe to Severe Non-proliferative Diabetic Retinopathy | ||
NCT05335122 | A Study to Evaluate the Efficacy and Safety of OTX-TIC (Travoprost) Intracameral Implant for Patients With Open-angle Glaucoma (OAG) or Ocular Hypertension (OHT) | ||
NCT05307081 | An Observational, Qualitative Study Assessing Eye Drop Administration | ||
NCT04989699 | Study Evaluating the Treatment of OTX-TKI for Subjects With Neovascular Age-related Macular Degeneration | ||
NCT04945824 | A Human Factors Study to Evaluate a Novel Intracanalicular Insertion Device in Healthy Subjects | ||
NCT04747977 | To Assess the Efficacy and Safety of OTX-DED for the Short-term Treatment of Signs and Symptoms of Dry Eye Disease | ||
NCT04539548 | A Study Assessing the Safety and Efficacy of Dextenza® for the Treatment of Ocular Pain and Inflammation Following Surgery for Pediatric Cataract | ||
NCT04362670 | Study to Evaluate the Safety, Tolerability, and Efficacy of OTX-CSI in Subjects With Dry Eye Disease. | ||
NCT04360174 | CLN-0045: Safety, and Efficacy of OTX-TIC in Participants With Open Angle Glaucoma or Ocular Hypertension | ||
NCT04061044 | A Study to Evaluate the Long Term Safety of OTX-TP (Sustained Release Travoprost) Intracanalicular Insert | ||
NCT04050865 | A Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Allergic Conjunctivitis | ||
NCT03630315 | CLN-0046: Treatment of AMD Subjects With OTX-TKI | ||
NCT02914509 | Phase 3 Study Evaluating Safety and Efficacy of OTX-TP in Subjects With OAG or OHT | ||
NCT02736175 | OTX-15:003: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Ocular Inflammation and Pain After Cataract Surgery | ||
NCT02312544 | Phase 2b Study Evaluating Safety and Efficacy of OTX-TP Compared to Timolol Drops in the Treatment of Subjects With Open Angle Glaucoma or Ocular Hypertension | ||
NCT02310815 | ReSure Sealant Post Approval Study | ||
NCT02309736 | OTX-14-002: Device Exposure Registry | ||
NCT02089113 | OTX-14-003: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Ocular Inflammation and Pain After Cataract Surgery | ||
NCT02034019 | Phase 3 Study Evaluating Safety and Efficacy of OTX-DP for Treatment of Ocular Inflammation and Pain After Cataract Surgery | ||
NCT01845038 | Multi-Arm Feasibility Study Evaluating OTX-TP Compared to Timolol in Treatment of Subjects With Open Angle Glaucoma | ||
NCT01800175 | Non-Significant Risk Feasibility Study to Assess Retention and Replacement of the OTX Punctum Plug | ||
NCT01666210 | Phase II Study Evaluating Safety/Efficacy of OTX-DP for Treatment of Ocular Inflammation and Pain After Cataract Surgery | ||
NCT01498224 | ReSure Sealant Pivotal Study | ||
NCT00774228 | I-ZIP Ocular Bandage Pivotal Study | ||
NCT05143281 | The SITE Study - Dexamethasone Ophthalmic Insert In OR on Day of Surgery Versus In-office Post-Op Day 1 | ||
NCT04530864 | Pre-Surgical Ocular Surface Treatment With Intracanalicular Dexamethasone Insert And Effect On Intraocular Lens Measurement Accuracy | ||
NCT04464629 | Assessing the Efficacy and Safety of DEXTENZA in Pseudo Phakic Patients Undergoing Gas Bubble Repair and Laser Following Retinal Detachment | ||
NCT04316936 | Omidria and Dexycu, or Omidria and Dextenza Compared to Topical Prednisolone Acetate 1% Following Cataract Surgery | ||
NCT04413279 | Lipiflow Treatment Alone vs. Lipiflow + Dextenza Treatment for Dry Eye Disease | ||
NCT04413253 | Xiidra vs. Xiidra + Dextenza Treatment for Dry Eye Disease | ||
NCT04396990 | The RESTORE Study, A Randomized, Controlled, Masked (Reading Center) Prospective Study | ||
NCT04863742 | Evaluation Of Vision Recovery And Comfort Index In Patients With Borderline/Mild Dry Eyes Undergoing FLACS With Premium IOL | ||
NCT04168112 | Intracanalicular Dexamethasone Insert for Post-Corneal Cross-Linking Inflammation and Pain- The LINK Study | ||
NCT04205916 | A Trial Evaluating Patient Preference of Dropless vs Drops Post Cataract Surgery | ||
NCT04728646 | Evaluation of Dextenza in Patients With Ocular GVHD and Effects on Ocular Surface Disease Outcomes | ||
NCT05372315 | Efficacy of Dextenza Insert in Upper vs Lower Punctum Following Cataract Surgery With PCIOL. | ||
NCT04200651 | Prospective Study on DEXTENZA® Safety And Efficacy Following Concomitant MIGS and Cataract Surgery | ||
NCT04687800 | Clinical Investigation of the Dextenza 0.4mg Intracanalicular Insert Delivery System Used in Cataract Surgery | ||
NCT05023304 | In Clinic Optometrist Insertion of Dextenza Prior to Cataract Surgery | ||
NCT04403516 | Dextenza in Pterygium Surgery | ||
NCT05116345 | DEXTENZA for the Treatment of Pain and Inflammation Following Surgical Trabeculectomy and Ahmed Valve Procedures | ||
NCT04708821 | DEXTENZA Therapy for Treatment of Allergic Conjunctivitis | ||
NCT04563559 | PREFERENTIAL Study | ||
NCT04563299 | Effect on Pain and Inflammation With DEXTENZA Treatment in Patients Undergoing Intravitreal Anti-VEGF Injections | ||
NCT04529512 | INtravitreal and Aqueous Dexamethasone Levels After DEXtenza |